Emergent BioSolutions gets gov't order for BioThrax

Tools

Emergent BioSolutions could earn up to $1.25 billion over the next 5 years for providing 44.8 million doses of its BioThrax anthrax vaccine to the U.S. government. The developer revealed in May the government was contemplating the contract. Report

Comments